Rifapentine comes under rifamycin class, which according to Sanofi-aventis has a higher inhibitory activity against Mycobacterium tuberculosis and a longer half-life than rifampin. With the objective of shortening
Sanofi-aventis and JDRF said that their partnership is expected to focus on therapeutics such as immune therapies and beta cell regeneration. As per the terms of the partnership,
Afinitor is approved for the treatment of patients with advanced renal cell carcinoma (RCC) whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted
HuCAL-derived is a fully human antibody in the therapeutic area of musculoskeletal diseases. MorphoSys said that in 2010 between four and six partnered programs could enter clinical trials.
Gen-Probe’s Aptima Trichomonas assay utilises the same nucleic acid amplification technologies as the Aptima Combo 2 assay for chlamydia and gonorrhea. The studies have shown that Gen-Probe’s Transcription-Mediated
The alliance between Servier and Galapagos builds on novel OA drug targets discovered by Galapagos through its proprietary platform. Galapagos is expected to take up the responsibility of
Evotec said that the advancement of EVT 101 into Phase II study is a part of an alliance between Evotec and Roche. Under this alliance Evotec is responsible
Lorcaserin is used for the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI = 30) or overweight (BMI = 27)
The results of the study were presented during the ongoing ESHRE (European Society of Human Reproduction and Embryology) conference in Rome by Matts Wikland. Vitrolife said that the
As per the terms of the agreement, JHP is expected to take up the responsibility for manufacturing and supply of a proprietary ophthalmic product, which is targeted for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.